D.L. Andress - Concepedia

Author

D.L. Andress

University of Washington

Also Known As

D Andress, D. ANDRESS, D. Andress, D. L. Andress, D.L. Andress, Daniel Andress

Publications

2.7K

Citations

H-Index

Concepts

All Affiliations

University of Washington Kidney Centre University of Groningen Heidelberg University Washington University in St. Louis

About

D.L. Andress is an author at University of Washington specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.7K
2	Public Health	1	1	53
3	African American Studies	1	1	53
4	Cell Biology	1	1	127
5	Epidemiology	1	1	53

D.L. Andress

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Adeera Levin, George L. Bakris, Mark E. Molitch, Kidney International Glomerular DiseaseNutritionUrologyRenal DiseaseRenal Function	2006	1.5K
Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. D.L. Andress, Roger S. Birnbaum Journal of Biological Chemistry	1992	348
Carboxy-Truncated Insulin-like Growth Factor-Binding Protein-5 Stimulates Mitogenesis in Osteoblast-like Cells D.L. Andress, Steven M. Loop, J Zapf, Biochemical and Biophysical Research Communications Developmental BiologyBone Morphogenic ProteinOsteoblast-like CellsOsteoporosisMedicine	1993	127
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease Orlando M. Gutiérrez, Tamara Isakova, D.L. Andress, Kidney International Glomerular DiseaseMetabolic SyndromeNutritionRenal FunctionRenal Disease	2008	76
Racial and ethnic differences in incident myocardial infarction in end-stage renal disease patients: The USRDS Bessie A. Young, Kyle Rudser, Bryan Kestenbaum, Kidney International EthnicityRacial DisparitiesHemodialysisHealth Care DisparityCardiovascular Epidemiology	2006	53
The Selective Vitamin D Receptor Activator for Albuminuria Lowering (VITAL) Study: Study Design and Baseline Characteristics Hiddo J.L. Heerspink, Rajiv Agarwal, Daniel W. Coyne, American Journal of Nephrology	2009	38
Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study Daniel W. Coyne, D.L. Andress, Michael Amdahl, Nephrology Dialysis Transplantation	2013	38
Cytokine accumulation in osteitis fibrosa of renal osteodystrophy Maria Eugênia Lammoglia Duarte, Eduardo Freese de Carvalho, Elisa A.S. Cruz, Brazilian Journal of Medical and Biological Research	2002	21
The use of SDS-PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis Alain Ficheux, Nathalie Gayrard, Ilan Szwarc, Nephrology Dialysis Transplantation	2010	18
Impact of elevated intact parathyroid hormone on mortality and renal disease progression in patients with chronic kidney disease stages 3 and 4 Carl V. Asche, Steven E. Marx, J Kim, Current Medical Research and Opinion	2012	10

Page 1